Pharmesis International Ltd. (SGX:BFK)

Pharmesis International Ratios and Metrics

Market cap in millions SGD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 29, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	14	18	3	3	3	7
Market Cap Growth	172.52%	573.89%	7.89%	-27.33%	-47.37%	32.56%
Enterprise Value	16	21	5	4	4	7
Last Close Price	0.43	0.57	0.10	0.11	0.15	0.28
PE Ratio	7.47	11.78	-	-	13.89	-
PS Ratio	1.09	1.44	0.32	0.26	0.31	0.69
PB Ratio	1.29	1.58	0.27	0.23	0.27	0.56
P/TBV Ratio	1.32	1.62	0.29	0.25	0.29	0.59
P/FCF Ratio	22.35	-	-	2.04	-	41.89
P/OCF Ratio	15.80	-	-	1.97	24.90	19.15
EV/Sales Ratio	1.27	1.67	0.56	0.42	0.40	0.78
EV/EBITDA Ratio	15.10	34.91	-	-	8.93	-
EV/EBIT Ratio	25.41	55.85	-	-	19.59	-
EV/FCF Ratio	26.00	-	-	3.34	-	47.32
Debt / Equity Ratio	0.26	0.26	0.31	0.29	0.28	0.27
Debt / EBITDA Ratio	2.66	4.12	-	-	5.89	-
Debt / FCF Ratio	4.59	-	-	2.61	-	20.53
Asset Turnover	0.84	0.67	0.50	0.53	0.57	0.51
Inventory Turnover	3.06	2.95	1.88	2.65	3.20	3.02
Quick Ratio	0.57	0.79	0.58	0.82	0.92	0.86
Current Ratio	1.07	1.06	1.09	1.12	1.21	1.14
Return on Equity (ROE)	18.14%	13.14%	-8.82%	-5.42%	3.33%	-9.57%
Return on Assets (ROA)	2.64%	1.25%	-1.90%	-1.66%	0.72%	-2.92%
Return on Capital (ROIC)	3.06%	1.70%	-2.42%	-2.10%	0.88%	-3.51%
Return on Capital Employed (ROCE)	5.90%	3.20%	-	-	1.70%	-
Earnings Yield	13.39%	8.49%	-34.12%	-27.61%	7.20%	-18.00%
FCF Yield	4.47%	-4.35%	-83.72%	49.05%	-5.71%	2.39%
Buyback Yield / Dilution	-14.03%	-13.08%	-14.85%	-	-	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.